Consolidated Statement of Stockholders' Equity - USD ($) shares in Millions, $ in Millions	Total	Common Stock [Member]	Capital in Excess of Par Value [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Loss [Member]	Noncontrolling Interests [Member]
Beginning balance at Dec. 31, 2020	$ 6,232.7	$ 193.7	$ 4,264.4	$ 2,371.7	$ (643.6)	$ 46.5
Beginning balance (in shares) at Dec. 31, 2020		193.7
Net earnings	393.7			382.1		11.6
Dividends paid to noncontrolling interests	(10.3)					(10.3)
Net change in pension asset/liability, net of taxes	1.0				1.0
Foreign currency translation	58.6				58.0	0.6
Change in fair value of derivative instruments, net of taxes	56.8				56.8
Compensation expense related to stock option plan grants	3.7		3.7
Common stock issued in: One purchase transactions	67.5	$ 0.6	66.9
Common stock issued in: One purchase transactions (in shares)		0.6
Stock option plans	30.2	$ 0.6	29.6
Stock option plans (in shares)		0.6
Employee stock purchase plan	7.0	$ 0.1	6.9
Employee stock purchase plan (in shares)		0.1
Shares issued to benefit plans	71.4	$ 0.6	70.8
Shares issued to benefit plans (in shares)		0.6
Deferred compensation and restricted stock	(37.9)	$ 0.3	(38.2)
Deferred compensation and restricted (in shares)		0.3
Cash dividends declared on common stock	(94.9)			(94.9)
Ending balance at Mar. 31, 2021	6,779.5	$ 195.9	4,404.1	2,658.9	(527.8)	48.4
Ending balance, (in shares) at Mar. 31, 2021		195.9
Beginning balance at Dec. 31, 2020	6,232.7	$ 193.7	4,264.4	2,371.7	(643.6)	46.5
Beginning balance (in shares) at Dec. 31, 2020		193.7
Net earnings	595.5
Net change in pension asset/liability, net of taxes	1.1
Change in fair value of derivative instruments, net of taxes	23.6
Compensation expense related to stock option plan grants	8.2
Ending balance at Jun. 30, 2021	8,354.0	$ 206.8	5,887.3	2,749.1	(530.5)	41.3
Ending balance, (in shares) at Jun. 30, 2021		206.8
Beginning balance at Mar. 31, 2021	6,779.5	$ 195.9	4,404.1	2,658.9	(527.8)	48.4
Beginning balance (in shares) at Mar. 31, 2021		195.9
Net earnings	201.8			190.2		11.6
Net purchase of subsidiary shares from noncontrolling interests	(11.0)					(11.0)
Dividends paid to noncontrolling interests	(7.4)					(7.4)
Net change in pension asset/liability, net of taxes	0.1				0.1
Foreign currency translation	30.1				30.4	(0.3)
Change in fair value of derivative instruments, net of taxes	(33.2)				(33.2)
Compensation expense related to stock option plan grants	4.5		4.5
Common stock issued in: One purchase transactions	13.0	$ 0.1	12.9
Common stock issued in: One purchase transactions (in shares)		0.1
Stock option plans	15.7	$ 0.3	15.4
Stock option plans (in shares)		0.3
Employee stock purchase plan	10.5	$ 0.1	10.4
Employee stock purchase plan (in shares)		0.1
Deferred compensation and restricted stock	12.2	$ 0.1	12.1
Deferred compensation and restricted (in shares)		0.1
Stock issuance from public offering	1,437.9	$ 10.3	1,427.6
Stock issuance from public offering (in shares)		10.3
Other compensation expense	0.3		0.3
Cash dividends declared on common stock	(100.0)			(100.0)
Ending balance at Jun. 30, 2021	8,354.0	$ 206.8	5,887.3	2,749.1	(530.5)	41.3
Ending balance, (in shares) at Jun. 30, 2021		206.8
Beginning balance at Dec. 31, 2021	$ 8,560.1	$ 208.5	6,143.7	2,882.3	(726.1)	51.7
Beginning balance (in shares) at Dec. 31, 2021	208.5	208.5
Net earnings	$ 439.1			438.7		0.4
Net purchase of subsidiary shares from noncontrolling interests	2.1					2.1
Dividends paid to noncontrolling interests	(0.6)					(0.6)
Net change in pension asset/liability, net of taxes	0.3				0.3
Foreign currency translation	15.0				14.9	0.1
Change in fair value of derivative instruments, net of taxes	45.2				45.2
Compensation expense related to stock option plan grants	5.7		5.7
Stock option plans	37.8	$ 0.7	37.1
Stock option plans (in shares)		0.7
Employee stock purchase plan	8.1	$ 0.1	8.0
Employee stock purchase plan (in shares)		0.1
Shares issued to benefit plans	74.4	$ 0.5	73.9
Shares issued to benefit plans (in shares)		0.5
Deferred compensation and restricted stock	(36.1)	$ 0.3	(36.4)
Deferred compensation and restricted (in shares)		0.3
Cash dividends declared on common stock	(108.0)			(108.0)
Ending balance at Mar. 31, 2022	9,043.1	$ 210.1	6,232.0	3,213.0	(665.7)	53.7
Ending balance, (in shares) at Mar. 31, 2022		210.1
Beginning balance at Dec. 31, 2021	$ 8,560.1	$ 208.5	6,143.7	2,882.3	(726.1)	51.7
Beginning balance (in shares) at Dec. 31, 2021	208.5	208.5
Net earnings	$ 724.2
Change in fair value of derivative instruments, net of taxes	71.8
Compensation expense related to stock option plan grants	$ 12.9
Stock option plans (in shares)	0.9
Ending balance at Jun. 30, 2022	$ 8,861.8	$ 210.3	6,267.0	3,388.7	(1,057.3)	53.1
Ending balance, (in shares) at Jun. 30, 2022	210.3	210.3
Beginning balance at Mar. 31, 2022	$ 9,043.1	$ 210.1	6,232.0	3,213.0	(665.7)	53.7
Beginning balance (in shares) at Mar. 31, 2022		210.1
Net earnings	285.1			284.2		0.9
Net purchase of subsidiary shares from noncontrolling interests	(1.0)					(1.0)
Dividends paid to noncontrolling interests	(0.4)					(0.4)
Net change in pension asset/liability, net of taxes	(0.3)				(0.3)
Foreign currency translation	(418.0)				(417.9)	(0.1)
Change in fair value of derivative instruments, net of taxes	26.6				26.6
Compensation expense related to stock option plan grants	7.2		7.2
Stock option plans	10.6	$ 0.2	10.4
Stock option plans (in shares)		0.2
Employee stock purchase plan	12.5		12.5
Deferred compensation and restricted stock	4.9		4.9
Cash dividends declared on common stock	(108.5)			(108.5)
Ending balance at Jun. 30, 2022	$ 8,861.8	$ 210.3	$ 6,267.0	$ 3,388.7	$ (1,057.3)	$ 53.1
Ending balance, (in shares) at Jun. 30, 2022	210.3	210.3